Methylprednisolone and Ganirelix acetate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Methylprednisolone and Ganirelix acetate together.

The phase IV clinical study analyzes what interactions people who take Methylprednisolone and Ganirelix acetate have. It is created by eHealthMe based on reports of 3 people who take the same drugs from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 01, 2022

3 people who take Methylprednisolone and Ganirelix acetate together, and have interactions are studied.


What is Methylprednisolone?

Methylprednisolone has active ingredients of methylprednisolone. It is often used in inflammation. eHealthMe is studying from 34,971 Methylprednisolone users for its effectiveness, alternative drugs and more.

What is Ganirelix acetate?

Ganirelix acetate has active ingredients of ganirelix acetate. eHealthMe is studying from 1,294 Ganirelix acetate users for its effectiveness, alternative drugs and more.

Number of Methylprednisolone and Ganirelix acetate reports submitted per year:

Methylprednisolone and Ganirelix acetate drug interactions.

Common Methylprednisolone and Ganirelix Acetate drug interactions by gender *:

female:

  1. Dizziness
  2. Nausea
  3. Vision blurred
  4. Abortion spontaneous
  5. Fatigue
  6. Flushing
  7. Injection site pain
  8. Maternal exposure during pregnancy

male:

n/a

Common Methylprednisolone and Ganirelix Acetate drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Dizziness
  2. Nausea
  3. Vision blurred

40-49:

n/a

50-59:

n/a

60+:

n/a

* Approximation only. Some reports may have incomplete information.

Do you take Methylprednisolone and Ganirelix acetate?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Methylprednisolone and Ganirelix acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Methylprednisolone interactions:

Browse all interactions between Methylprednisolone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Ganirelix acetate interactions:

Browse all interactions between Ganirelix acetate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on methylprednisolone and ganirelix acetate (the active ingredients of Methylprednisolone and Ganirelix acetate, respectively), and Methylprednisolone and Ganirelix acetate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Methylprednisolone and Ganirelix acetate.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: